Unit sales to Zentiva may boost Sanofi India

| Updated on September 11, 2019 Published on September 12, 2019


The board of Sanofi India has approved a transaction for the slump sale and transfer of its manufacturing facility at Ankleshwar, Gujarat, to Zentiva and its legal entity in India, Zentiva Private Limited for ₹261.70 crore, subject to customary working capital adjustments. This transaction is subject to shareholders’ approval and the completion of certain conditions as defined under the Business Transfer Agreement. Shareholders will closely monitor further developments.

Published on September 12, 2019
This article is closed for comments.
Please Email the Editor